Singh J - Search Results

1

Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology.

Quiroz JA, Singh J, Gould TD, Denicoff KD, Zarate CA, Manji HK. Quiroz JA, et al. Among authors: singh j. Mol Psychiatry. 2004 Aug;9(8):756-76. doi: 10.1038/sj.mp.4001521. Mol Psychiatry. 2004. PMID: 15136795 Review.

2

An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression.

Zarate CA Jr, Quiroz JA, Singh JB, Denicoff KD, De Jesus G, Luckenbaugh DA, Charney DS, Manji HK. Zarate CA Jr, et al. Biol Psychiatry. 2005 Feb 15;57(4):430-2. doi: 10.1016/j.biopsych.2004.11.023. Biol Psychiatry. 2005. PMID: 15705360 Clinical Trial.

3

Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets.

Carlson PJ, Singh JB, Zarate CA Jr, Drevets WC, Manji HK. Carlson PJ, et al. Among authors: singh jb. NeuroRx. 2006 Jan;3(1):22-41. doi: 10.1016/j.nurx.2005.12.009. NeuroRx. 2006. PMID: 16490411 Free PMC article. Review.

4

Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trials.

Singh JB, Zarate CA Jr. Singh JB, et al. Bipolar Disord. 2006 Dec;8(6):696-709. doi: 10.1111/j.1399-5618.2006.00371.x. Bipolar Disord. 2006. PMID: 17156156 Review.

5

Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.

Gould TD, Quiroz JA, Singh J, Zarate CA, Manji HK. Gould TD, et al. Among authors: singh j. Mol Psychiatry. 2004 Aug;9(8):734-55. doi: 10.1038/sj.mp.4001518. Mol Psychiatry. 2004. PMID: 15136794 Review.

6

Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system.

Zarate CA Jr, Du J, Quiroz J, Gray NA, Denicoff KD, Singh J, Charney DS, Manji HK. Zarate CA Jr, et al. Among authors: singh j. Ann N Y Acad Sci. 2003 Nov;1003:273-91. doi: 10.1196/annals.1300.017. Ann N Y Acad Sci. 2003. PMID: 14684452 Review.

7

Pramipexole for bipolar II depression: a placebo-controlled proof of concept study.

Zarate CA Jr, Payne JL, Singh J, Quiroz JA, Luckenbaugh DA, Denicoff KD, Charney DS, Manji HK. Zarate CA Jr, et al. Among authors: singh j. Biol Psychiatry. 2004 Jul 1;56(1):54-60. doi: 10.1016/j.biopsych.2004.03.013. Biol Psychiatry. 2004. PMID: 15219473 Clinical Trial.

8

Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder.

Zarate CA Jr, Singh J, Manji HK. Zarate CA Jr, et al. Among authors: singh j. Biol Psychiatry. 2006 Jun 1;59(11):1006-20. doi: 10.1016/j.biopsych.2005.10.021. Epub 2006 Feb 17. Biol Psychiatry. 2006. PMID: 16487491 Review.

9

The underlying neurobiology of bipolar disorder.

Manji HK, Quiroz JA, Payne JL, Singh J, Lopes BP, Viegas JS, Zarate CA. Manji HK, et al. Among authors: singh j. World Psychiatry. 2003 Oct;2(3):136-46. World Psychiatry. 2003. PMID: 16946919 Free PMC article.

10

Regional cerebral glucose metabolic abnormalities in bipolar II depression.

Mah L, Zarate CA Jr, Singh J, Duan YF, Luckenbaugh DA, Manji HK, Drevets WC. Mah L, et al. Among authors: singh j. Biol Psychiatry. 2007 Mar 15;61(6):765-75. doi: 10.1016/j.biopsych.2006.06.009. Epub 2006 Oct 6. Biol Psychiatry. 2007. PMID: 17027930

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,968 results

Search Page

Filters